Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

DIH Holding US Inc DHAI

Alternate Symbol(s):  DHAIW

DIH Holding US, Inc. is a global robotics and virtual reality (VR) technology provider in the rehabilitation and human performance industry. The Company offers an integrated solution for the entire continuum of care and multiple markets, including hospitals, clinics, research and home. Its rehabilitation hospitals and outpatient clinics offering solutions include ArmeoPower, ArmeoSpring, ArmeoSpring Pro, ArmeoSenso, Erigo, Lokomat, SafeGait 360 by Gorbel, RYSEN, Andago, C-Mill, and HocoNet. Its Research & Academia offering solutions include GRAIL, CAREN Extended, M-Gait, and D-Flow. The ArmeoSpring Pro is a cutting-edge medical device designed to bring upper limb rehabilitation to the next level. ArmeoPower guides the initial phases of arm and hand function recovery. ArmeoSpring supports the recovery of arm and hand functions. ArmeoSenso is a sensor-based solution for arm function recovery. HocoNet is a software platform connecting product portfolio across the entire continuum of care.


NDAQ:DHAI - Post by User

Bullboard Posts
Post by donmayneon May 08, 2024 8:38pm
74 Views
Post# 36030115

Q3 looks great!

Q3 looks great!DHAI Achieved profitability in Q3 24.  This is ahead of schedule.  10K will be posted by July and guidance will probably be revenues of $100 M.  If so, EPS will be more than $0.25.  At a 20x multiple, this should trade above $5.  Current price is $1.65.
Their proxy filed in November suggests a 40% growth in the next two years then levelling off to 25%.

Unfortunate delay in their merger caused it to fall off everyone's radar.  


Bullboard Posts